Cargando…
Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)—A Meta-analysis
CONTEXT: The Afirma® GSC aids in risk stratifying indeterminate thyroid nodule cytology (ITN). The 2018 GSC validation study (VS) reported a sensitivity (SN) of 91%, specificity (SP) of 68%, positive predictive value (PPV) of 47%, and negative predictive value (NPV) of 96%. Since then, 13 independen...
Autores principales: | Nasr, Christian E, Andrioli, Massimiliano, Endo, Mayumi, Harrell, R Mack, Livhits, Masha J, Osakwe, Ibitoro, Polavarapu, Preethi, Siperstein, Allan, Wei, Shuanzeng, Zheng, Xingyu, Jiang, Ruochen, Hao, Yangyang, Huang, J I ng, Klopper, Joshua P, Kloos, Richard T, Kennedy, Giulia, Angell, Trevor E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188305/ https://www.ncbi.nlm.nih.gov/pubmed/36470585 http://dx.doi.org/10.1210/clinem/dgac688 |
Ejemplares similares
-
LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) - A Meta-analysis
por: Nasr, Christian E, et al.
Publicado: (2022) -
MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier
por: Waguespack, Steven, et al.
Publicado: (2019) -
Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules
por: Polavarapu, Preethi, et al.
Publicado: (2021) -
Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
por: Kim, Na Eun, et al.
Publicado: (2023) -
THU678 Real-world Performance Of Afirma Genomic Sequencing Classifier (GSC) In A Community Healthcare Setting
por: Master, Vidisha, et al.
Publicado: (2023)